Your browser doesn't support javascript.
loading
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong).
Park, Jin-Sun; Shin, Joon-Han; Hong, Taek-Jong; Seo, Hong-Seog; Shim, Wan-Joo; Baek, Sang-Hong; Jeong, Jin-Ok; Ahn, Youngkeun; Kang, Woong-Chol; Kim, Young-Hak; Kim, Sang-Hyun; Hyon, Min-Su; Choi, Dong-Hoon; Nam, Chang-Wook; Park, Tae-Ho; Lee, Sang-Chol; Kim, Hyo-Soo.
Affiliation
  • Park JS; Department of Cardiology, Ajou University School of Medicine, Suwon.
  • Shin JH; Department of Cardiology, Ajou University School of Medicine, Suwon.
  • Hong TJ; Division of Cardiology, Pusan National University Hospital, Busan.
  • Seo HS; Division of Cardiology, Korea University Guro Hospital, Korea University College of Medicine.
  • Shim WJ; Division of Cardiology, Korea University Anam Hospital.
  • Baek SH; Cardiovascular Division, Catholic University of Korea, Seoul St Mary's Hospital, Seoul.
  • Jeong JO; Division of Cardiology, Chungnam National University Hospital, Daejeon.
  • Ahn Y; Division of Cardiology, Chonnam National University Hospital, Gwangju.
  • Kang WC; Division of Cardiology, Gachon University Gil Hospital, Incheon.
  • Kim YH; Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan.
  • Kim SH; Division of Cardiology, Seoul Metropolitan Government Seoul National University Boramae Medical Center.
  • Hyon MS; Division of Cardiology, Soonchunhyang University Hospital.
  • Choi DH; Division of Cardiology, Yonsei University Severance Hospital, Seoul.
  • Nam CW; Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu.
  • Park TH; Division of Cardiology, Dong-A University Hospital, Busan.
  • Lee SC; Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine.
  • Kim HS; Department of Internal Medicine, Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Drug Des Devel Ther ; 10: 2599-609, 2016.
Article in En | MEDLINE | ID: mdl-27574399
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyslipidemias / Rosuvastatin Calcium / Olmesartan Medoxomil / Hypertension / Antihypertensive Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyslipidemias / Rosuvastatin Calcium / Olmesartan Medoxomil / Hypertension / Antihypertensive Agents Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Drug Des Devel Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Country of publication: Nueva Zelanda